Nektar Therapeutics (NKTR) PT Raised to $63 at Evercore ISI; 'Highlights from 4Q earnings call'
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $66.84 -0.39%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Join SI Premium – FREE
Evercore ISI raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $63.00 (from $31.00) while maintaining a In Line rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- Oxford Nanopore (ONT:LN) (ONTTF) PT Raised to GBP2.10 at Deutsche Bank
- Goldman Sachs Upgrades SK Innovation Co Ltd (096770:KS) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
